Načítá se...
Targeted alpha therapy using short-lived alpha-particles and the promise of nanobodies as targeting vehicle
Introduction: The combination of a targeted biomolecule that specifically defines the target and a radionuclide that delivers a cytotoxic payload offers a specific way to destroy cancer cells. Targeted radionuclide therapy (TRNT) aims to deliver cytotoxic radiation to cancer cells and causes minimal...
Uloženo v:
| Vydáno v: | Expert Opin Biol Ther |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Taylor & Francis
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4940885/ https://ncbi.nlm.nih.gov/pubmed/27145158 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14712598.2016.1185412 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|